肺癌同步放化疗患者支持治疗建议
ESTRO与ESMO专家组针对III期非小细胞肺癌(NSCLC)患者同步放化疗(CCRT)的支持治疗提出建议,涵盖戒烟、营养、运动、急性食管炎与吞咽困难防治、咳嗽与呼吸困难处理、皮肤反应、疲乏、恶心呕吐预防、心脏病防治及放疗技术与化疗调整优化,并识别知识缺口。
要点
- CCRT毒性影响多器官系统,可致急性或永久性副作用甚至致命,支持治疗至关重要。
- 支持治疗涵盖戒烟、营养、运动、食管炎与吞咽困难、咳嗽与呼吸困难、皮肤反应、疲乏、恶心呕吐及心脏病防治。
- 免疫治疗时代需优化放疗技术与化疗调整以减少毒性。
核心结论
- 对适合的III期NSCLC患者,CCRT后序贯度伐利尤单抗为标准治疗,但CCRT毒性大,支持治疗极为重要。
研究设计与样本
- ESTRO与ESMO专家组识别支持治疗重点条目并形成建议,同时识别知识缺口。
主要发现
- 专家组识别的重点条目包括戒烟、营养(含厌食防治)、运动、急性食管炎与吞咽困难防治、咳嗽与呼吸困难治疗、皮肤反应治疗、疲乏治疗、恶心呕吐预防、心脏病防治及放疗技术与化疗调整优化。
临床怎么用
- 在III期NSCLC患者CCRT期间及前后,应系统评估并管理戒烟、营养、运动、食管炎与吞咽困难、咳嗽与呼吸困难、皮肤反应、疲乏、恶心呕吐及心脏病风险。
局限性
- 文中识别了知识缺口,未来需投入研究以改善支持治疗,从而提高患者生活质量和生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Concurrent chemotherapy and radiotherapy (CCRT) followed by durvalumab immune therapy in appropriate patients is considered to be the standard of care in most fit stage III non-small-cell lung cancer (NSCLC) patients. However, CCRT is a toxic treatment that affects all organ systems and may cause acute and permanent side effects, some of which may be lethal. Supportive care is therefore of utmost importance in this clinical setting. A group of experts from the European Society for Therapeutic Radiology and Oncology (ESTRO) and the European Society of Medical Oncology (ESMO) identified the following items of importance for further improvement of supportive care: smoking cessation; nutrition before and during CCRT (including treatment and prevention of anorexia); physical exercise before and during CCRT; prevention and treatment of acute esophagitis and dysphagia; treatment of cough and dyspnea; treatment of skin reactions; treatment of fatigue; prophylaxis of nausea and emesis; prevention, diagnosis, and treatment of cardiac disease and damage; and optimization of radiotherapy techniques and chemotherapy adjustments to reduce toxicity in the era of immune therapy. The resulting recommendations are summarized in this manuscript and knowledge gaps identified, in which future investments are needed to improve supportive care and hence quality of life and survival for our stage III NSCLC patients.
引用
- De Ruysscher D, Faivre-Finn C, Nackaerts K, et al. Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer. Ann Oncol. 2020. PMID: 31912794. doi:10.1016/j.annonc.2019.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。